{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:00:16Z","timestamp":1760346016808},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T00:00:00Z","timestamp":1201651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present investigation was undertaken to study the comparative effectiveness of beta\u2010adrenergic antagonist propranolol and calcium channel blocker verapamil on <jats:sc>l<\/jats:sc>\u2010thyroxine\u2010induced alteration on glycemic control and histamine sensitivity on rats and guinea pigs, respectively. Injection of <jats:sc>l<\/jats:sc>\u2010thyroxine sodium every alternate day for 3\u2003weeks in guinea pigs (75\u2003\u03bcg\/kg, i.p.) and rats (75\u2003mg\/kg, s.c.) produced a condition similar to thyrotoxicosis. Verapamil and propranolol administered daily in the third week along with <jats:sc>l<\/jats:sc>\u2010thyroxine to two separate groups of hyperthyroid animals reversed thyroxine\u2010induced loss in body weight, reduction in serum TSH levels, and rise in body temperature. Effect on glucose metabolism and insulin sensitivity was studied on rats. Compared to normal rats, <jats:sc>l<\/jats:sc>\u2010thyroxine\u2010treated animals showed a state of hyperglycemia, hyperinsulinemia, impaired glucose tolerance, and insulin resistance. Propranolol (10\u2003mg\/kg, i.p.) treatment significantly decreased fasting serum glucose levels without affecting serum insulin levels, AUC glucose, and <jats:italic>K<\/jats:italic><jats:sub>ITT<\/jats:sub> values. Treatment with verapamil (5\u2003mg\/kg, i.p.) significantly reduced fasting serum glucose and insulin levels, AUC glucose, and significantly increased <jats:italic>K<\/jats:italic><jats:sub>ITT<\/jats:sub> values. Effect of propranolol (15\u2003mg\/kg, orally) and verapamil (20\u2003mg\/kg, orally) treatment on histamine sensitivity was studied on <jats:sc>l<\/jats:sc>\u2010thyroxine\u2010treated guinea pigs. Compared to normal guinea pigs, <jats:sc>l<\/jats:sc>\u2010thyroxine\u2010treated guinea pigs showed an increased sensitivity to histamine\u2010induced asphyxia. Verapamil treatment reversed this increased histamine sensitivity while propranolol aggravated it. In conclusion, compared to propranolol, verapamil has advantageous effects on glucose metabolism, insulin and histamine sensitivity and could therefore be a valuable addition as an adjunctive therapy option currently available for thyrotoxicosis associated with diabetes and\/or anaphylaxis.<\/jats:p>","DOI":"10.1111\/j.1472-8206.2007.00559.x","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T15:48:34Z","timestamp":1201708114000},"page":"53-59","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative influence of propranolol and verapamil on glycemic control and histamine sensitivity associated with <scp>l<\/scp>\u2010thyroxine\u2010induced hyperthyroidism \u2013 an experimental study"],"prefix":"10.1111","volume":"22","author":[{"given":"Parloop A.","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmesh","family":"Makwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,30]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960230605"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1450391"},{"key":"e_1_2_7_4_2","first-page":"131","article-title":"Impairment of glucose tolerance in hyperthyroidism","volume":"18","author":"Tauveron I.","year":"1992","journal-title":"Diabetes Metab."},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18584"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.135.2.649"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1600285"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1440347"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1076\/13813455199908107041QFT273"},{"key":"e_1_2_7_10_2","first-page":"15","article-title":"The effect of thyroid disease on diabetes","volume":"12","author":"Gottlieb P.A.","year":"1994","journal-title":"Clin. Diabetes"},{"key":"e_1_2_7_11_2","first-page":"43","article-title":"Glucose tolerance and insulin secretion in patients with hyperthyroidism: pathogenesis of disturbances and therapeutic consequences","volume":"49","author":"Gasinka T.","year":"1994","journal-title":"Pol. Tyg. Lek."},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.5.1857"},{"key":"e_1_2_7_13_2","first-page":"36","article-title":"An overview of the diagnosis and treatment of the patient with thyroid disease","volume":"58","author":"Einhorn D.","year":"1990","journal-title":"Mod. Med."},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90681-Z"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2004.07.003"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0710271"},{"key":"e_1_2_7_17_2","first-page":"473","article-title":"Heart and thyroid","volume":"56","author":"Klein M.","year":"1995","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90318-3"},{"key":"e_1_2_7_19_2","first-page":"49","article-title":"Calcium antagonist: history and perspective","volume":"21","author":"Triggle D.J.","year":"1990","journal-title":"Stroke"},{"key":"e_1_2_7_20_2","first-page":"183S","article-title":"Thyroidal effects and lipid turnover","volume":"2","author":"Krickler D.M.","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_2_7_21_2","first-page":"57","article-title":"The therapy of aged diabetic hypertensives","volume":"93","author":"Varricchio M.","year":"1996","journal-title":"Arch. Gerontol. Geriatr."},{"key":"e_1_2_7_22_2","first-page":"150","article-title":"Factors influencing an anaphylactoid reaction in the rat","volume":"6","author":"Leger J.","year":"1947","journal-title":"Proc. Fed. Am. Soc. Exp. Biol."},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-45-11799"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-87-21454"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.88.2.176"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90632-0"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(85)90261-4"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1983.tb01616.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01212550\">"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1998.8.1165"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ph.48.030186.002503"},{"key":"e_1_2_7_32_2","first-page":"102","volume-title":"The thyroid and its diseases","author":"Degroot L.J.","year":"1984"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.34.339"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1009208"},{"key":"e_1_2_7_35_2","first-page":"101","article-title":"Effects of antihypertensive therapy on glucose tolerance: focus on calcium antagonists","volume":"735","author":"Hedner T.","year":"1991","journal-title":"J. Intern. Med. Suppl."},{"key":"e_1_2_7_36_2","first-page":"108","article-title":"Insulin resistance as an intermediary endpoint","volume":"2","author":"Lithell H.O.","year":"1997","journal-title":"Blood Press. Suppl."},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1373"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000229098"},{"key":"e_1_2_7_39_2","first-page":"29","article-title":"Direct effects of hydrogen peroxide on airway smooth muscle tone: Roles of Ca(2+) influx and Rho\u2010kinase","volume":"10","author":"Kojima K.","year":"2006","journal-title":"Eur. J. Pharmacol."}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.2007.00559.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.2007.00559.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T12:20:04Z","timestamp":1697026804000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.2007.00559.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,30]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1472-8206.2007.00559.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.2007.00559.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,30]]},"assertion":[{"value":"2008-01-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}